# Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction

> **NCT00374985** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johannes Gutenberg University Mainz** · enrollment: 25 (actual)

## Conditions studied

- Esophageal Neoplasms
- Stomach Neoplasms

## Interventions

- **DRUG:** Docetaxel, Oxaliplatin
- **PROCEDURE:** Radiotherapy

## Key facts

- **NCT ID:** NCT00374985
- **Lead sponsor:** Johannes Gutenberg University Mainz
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374985, "Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00374985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*